• Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss

  • Sep 24 2024
  • Length: 22 mins
  • Podcast

Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss

Listen for free

View show details

  • Summary

  • Rep. Frank Pallone’s misunderstanding of how the pediatric priority review voucher program works has been one factor undermining support for an incentive that brings new drugs to kids, argues Washington Editor Steve Usdin on the latest BioCentury This Week podcast. Usdin explains how the voucher process works and why it’s valuable to the country’s youngest patients, as well as to small biotechs and larger biopharma alike.
    Usdin also discusses the latest twists and turns for the Biosecure Act, and BioCentury’s Stephen Hansen assesses the obesity data from Novo Nordisk that destroyed more than $30 billion in value for the Danish pharma. This episode of BioCentury This Week was sponsored by Parexel Biotech.

    View full story: https://www.biocentury.com/article/653633

    00:01 - Sponsor Message: Parexel Biotech
    01:47 - Pediatric PRVs
    06:42 - Biosecure Act
    12:44 - Novo's Obesity Miss

    To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com.

    Reach us by sending a text
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Show more Show less

What listeners say about Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available